Relay Therapeutics (RLAY) PT Raised to $17 at Citizens Following ESMO-TAT Update

March 17, 2026 5:20 AM

Citizens analyst Silvan Turkcan raised the price target on Relay Therapeutics (NASDAQ: RLAY) to $17.00 (from $15.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found